Extracellular HIV-tat induces cyclooxygenase-2 in glial cells through activation of nuclear factor of activated T cells

Journal of Immunology

Volumn 180, Issue 1, 2008, Pages 530-540

  Blanco, Almudena ^a   Álvarez, Susana ^b   Fresno, Manuel ^b   Muñoz Fernández, María Ángeles ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NUCLEAR FACTOR; PROSTAGLANDIN E2; PROTEIN C JUN; PROTEIN TAM 67; STRESS ACTIVATED PROTEIN KINASE; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG; PTGS2 PROTEIN, HUMAN;

ARTICLE; ASTROCYTE; ASTROCYTOMA CELL; BINDING SITE; CANCER CELL CULTURE; CELL NUCLEUS; CONTROLLED STUDY; ENZYME ACTIVITY; EXTRACELLULAR SPACE; GENE DELETION; GENE MUTATION; GENE TRANSLOCATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GLIA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; PRIORITY JOURNAL; PROMOTER REGION; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; PROTEIN INDUCTION; REGULATORY MECHANISM; REPORTER GENE; T LYMPHOCYTE ACTIVATION; CELL LINE; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; GLIA; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; METABOLISM; T LYMPHOCYTE; UPREGULATION; VIROLOGY;

ASTROCYTES; CELL LINE; CELL NUCLEUS; CYCLOOXYGENASE 2; DINOPROSTONE; GENE EXPRESSION REGULATION; HIV-1; HUMANS; NEUROGLIA; NF-KAPPA B; NFATC TRANSCRIPTION FACTORS; PROMOTER REGIONS (GENETICS); T-LYMPHOCYTES; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 40449132279     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.1.530     Document Type: Article

References (74)

1. McArthur, J. C., N. Haughey, S. Gartner, K. Conant, C. Pardo, A. Nath, and N. Sacktor. 2003. Human immunodeficiency virus-associated dementia: an evolving disease. J. Neurovirol. 9: 205-221.
2. Neuenburg, J. K., H. R. Brodt, B. G. Herndier, M. Bickel, P. Bacchetti, R. W. Price, R. M. Grant, and W. Schlote. 2002. HIV-related neuropathology, 1985 to 1999: rising prevalence of HIV encephalopathy in the era of highly active antiretroviral therapy. J. Acquired Immune Defic. Syndr. 31: 171-177.
3. Dore, G. J., A. McDonald, Y. Li, J. M. Kaldor, and B. J. Brew. 2003. Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 17: 1539-1545.
4. Gonzalez-Scarano, F., and J. Martin-Garcia. 2005. The neuropathogenesis of AIDS. Nat. Rev. Immunol. 5: 69-81.
5. Peruzzi, F., V. Bergonzini, S. Aprea, K. Reiss, B. E. Sawaya, J. Rappaport, S. Amini, and K. Khalili. 2005. Cross talk between growth factors and viral and cellular factors alters neuronal signaling pathways: implication for HIV-associated dementia. Brain Res. Rev. 50: 114-125.
6. Wesselingh, S. L., and K. A. Thompson. 2001. Immunopathogenesis of HIV-associated dementia. Curr. Opin. Neurol. 14: 375-379.
7. Kramer-Hammerle, S., I. Rothenaigner, H. Wolff, J. E. Bell, and R. Brack-Werner. 2005. Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus. Virus Res. 111: 194-213.
8. King, J. E., E. A. Eugenin, C. M. Buckner, and J. W. Berman. 2006. HIV Tat and neurotoxicity. Microbes Infect. 8: 1347-1357.
9. Munoz-Fernandez, M. A., and M. Fresno. 1998. The role of tumour necrosis factor, interleukin 6, interferon-γ and inducible nitric oxide synthase in the development and pathology of the nervous system. Prog. Neurobiol. 56: 307-340.
10. Peruzzi, F. 2006. The multiple functions of HIV-1 Tat: proliferation versus apoptosis. Front. Biosci. 11: 708-717.
11. Haughey, N. J., and M. P. Mattson. 2002. Calcium dysregulation and neuronal apoptosis by the HIV-1 proteins Tat and gp120. J. Acquired Immune Defic. Syndr. 31 (Suppl. 2): S55-S61.
12. Ensoli, B., L. Buonaguro, G. Barillari, V. Fiorelli, R. Gendelman, R. A. Morgan, P. Wingfield, and R. C. Gallo. 1993. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J. Virol. 67: 277-287.
13. Tardieu, M., C. Hery, and S. Peudenier. 1992. Neurotoxicity of macrophages infected by HIV1. Cell Biol. Toxicol. 8: 117-121.
14. Chauhan, A., J. Turchan, C. Pocernich, A. Bruce-Keller, S. Roth, D. A. Butterfield, E. O. Major, and A. Nath. 2003. Intracellular human immunodeficiency virus Tat expression in astrocytes promotes astrocyte survival but induces potent neurotoxicity at distant sites via axonal transport. J. Biol. Chem. 278: 13512-13519.
15. Wesselingh, S. L., C. Power, J. D. Glass, W. R. Tyor, J. C. McArthur, J. M. Farber, J. W. Griffin, and D. E. Griffin. 1993. Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia. Ann. Neurol. 33: 576-582.
16. Wiley, C. A., M. Baldwin, and C. L. Achim. 1996. Expression of HIV regulatory and structural mRNA in the central nervous system. AIDS 10: 843-847.
17. Aldovini, A., C. Debouck, M. B. Feinberg, M. Rosenberg, S. K. Arya, and F. Wong-Staal. 1986. Synthesis of the complete trans-activation gene product of human T-lymphotropic virus type III in Escherichia coli: demonstration of immunogenicity in vivo and expression in vitro. Proc. Natl. Acad. Sci. USA 83: 6672-6676.
18. Jones, M., K. Olafson, M. R. Del Bigio, J. Peeling, and A. Nath. 1998. Intraventricular injection of human immunodeficiency virus type 1 (HIV-1) tat protein causes inflammation, gliosis, apoptosis, and ventricular enlargement. J. Neuropathol. Exp. Neurol. 57: 563-570.
19. Kim, B. O., Y. Liu, Y. Ruan, Z. C. Xu, L. Schantz, and J. J. He. 2003. Neuropathologies in transgenic mice expressing human immunodeficiency virus type 1 Tat protein under the regulation of the astrocyte-specific glial fibrillary acidic protein promoter and doxycycline. Am. J. Pathol. 162: 1693-1707.
20. Mattson, M. P., N. J. Haughey, and A. Nath. 2005. Cell death in HIV dementia. Cell Death Differ. 12 (Suppl. 1): 893-904.
21. Eugenin, E. A., G. Dyer, T. M. Calderon, and J. W. Berman. 2005. HIV-1 tat protein induces a migratory phenotype in human fetal microglia by a CCL2 (MCP-1)-dependent mechanism: possible role in NeuroAIDS. Glia 49: 501-510.
22. 2+, and the release of MCP-1, RANTES, and IL-6 by astrocytes treated with opiates and HIV-1 Tat. Glia 50: 91-106.
23. Nath, A., N. J. Haughey, M. Jones, C. Anderson, J. E. Bell, and J. D. Geiger. 2000. Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine. Ann. Neurol. 47: 186-194.
24. Behnisch, T., W. Francesconi, and P. P. Sanna. 2004. HIV secreted protein Tat prevents long-term potentiation in the hippocampal CA1 region. Brain Res. 1012: 187-189.
25. Pu, H., J. Tian, G. Flora, Y. W. Lee, A. Nath, B. Hennig, and M. Toborek. 2003. HIV-1 Tat protein up-regulates inflammatory mediators and induces monocyte invasion into the brain. Mol. Cell. Neurosci. 24: 224-237.
26. Mayne, M., A. C. Bratanich, P. Chen, F. Rana, A. Nath, and C. Power. 1998. HIV-1 Tat molecular diversity and induction of TNF-α: implications for HIV-induced neurological disease. Neuroimmunomodulation 5: 184-192.
27. Liu, X., M. Jana, S. Dasgupta, S. Koka, J. He, C. Wood, and K. Pahan. 2002. Human immunodeficiency virus type 1 (HIV-1) Tat induces nitric-oxide synthase in human astroglia. J. Biol. Chem. 277: 39312-39319.
28. Woodman, S. E., E. N. Benveniste, A. Nath, and J. W. Berman. 1999. Human immunodeficiency virus type 1 TAT protein induces adhesion molecule expression in astrocytes. J. Neurovirol. 5: 678-684.
29. Bagetta, G., M. T. Corasaniti, A. M. Paoletti, L. Berliocchi, R. Nistico, A. M. Giammarioli, W. Malorni, and A. Finazzi-Agro. 1998. HIV-1 gp120-induced apoptosis in the rat neocortex involves enhanced expression of cyclooxygenase type 2 (COX-2). Biochem. Biophys. Res. Commun. 244: 819-824.
30. Griffin, D. E., S. L. Wesselingh, and J. C. McArthur. 1994. Elevated central nervous system prostaglandins in human immunodeficiency virus-associated dementia. Ann. Neurol. 35: 592-597.
31. Fiala, M., Q. N. Liu, J. Sayre, V. Pop, V. Brahmandam, M. C. Graves, and H. V. Vinters. 2002. Cyclooxygenase-2-positive macrophages infiltrate the Alzheimer's disease brain and damage the blood-brain barrier. Eur. J. Clin. Invest. 32: 360-371.
32. Tzeng, S. F., H. Y. Hsiao, and O. T. Mak. 2005. Prostaglandins and cyclooxygenases in glial cells during brain inflammation. Curr. Drug Targets Inflamm. Allergy. 4: 335-340.
33. Vane, J. R., Y. S. Bakhle, and R. M. Botting. 1998. Cyclooxygenases 1 and 2. Annu. Rev. Pharmacol. Toxicol. 38: 97-120.
34. Smith, W. L., D. L. DeWitt, and R. M. Garavito. 2000. Cyclooxygenases: structural, cellular, and molecular biology. Annu. Rev. Biochem. 69: 145-182.
35. Yamagata, K., K. I. Andreasson, W. E. Kaufmann, C. A. Barnes, and P. F. Worley. 1993. Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron 11: 371-386.
36. Yamamoto, K., T. Arakawa, N. Ueda, and S. Yamamoto. 1995. Transcriptional roles of nuclear factor κB and nuclear factor- interleukin-6 in the tumor necrosis factor α-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells. J. Biol. Chem. 270: 31315-31320.
37. Mestre, J. R., P. J. Mackrell, D. E. Rivadeneira, P. P. Stapleton, T. Tanabe, and J. M. Daly. 2001. Redundancy in the signaling pathways and promoter elements regulating cyclooxygenase-2 gene expression in endotoxin-treated macrophage/ monocytic cells. J. Biol. Chem. 276: 3977-3982.
38. Iniguez, M. A., S. Martinez-Martinez, C. Punzon, J. M. Redondo, and M. Fresno. 2000. An essential role of the nuclear factor of activated T cells in the regulation of the expression of the cyclooxygenase-2 gene in human T lymphocytes. J. Biol. Chem. 275: 23627-23635.
39. Hernandez, G. L., O. V. Volpert, M. A. Iniguez, E. Lorenzo, S. Martinez-Martinez, R. Grau, M. Fresno, and J. M. Redondo. 2001. Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2. J. Exp. Med. 193: 607-620.
40. Subbaramaiah, K., W. J. Chung, and A. J. Dannenberg. 1998. Ceramide regulates the transcription of cyclooxygenase-2: evidence for involvement of extracellular signal-regulated kinase/c-Jun N-terminal kinase and p38 mitogen-activated protein kinase pathways. J. Biol. Chem. 273: 32943-32949.
41. Hogan, P. G., L. Chen, J. Nardone, and A. Rao. 2003. Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev. 17: 2205-2232.
42. Chang, L., and M. Karin. 2001. Mammalian MAP kinase signalling cascades. Nature 410: 37-40.
43. Alvarez, S., M. J. Serramia, M. Fresno, and M. Munoz-Fernandez. 2005. Human immunodeficiency virus type 1 envelope glycoprotein 120 induces cyclooxygenase-2 expression in neuroblastoma cells through a nuclear factor-κB and activating protein-1 mediated mechanism. J. Neurochem. 94: 850-861.
44. 2 synthesis in human neuroblastoma cells: involvement of p38 mitogen-activated protein kinase and nuclear factor-κB. J. Neurochem. 75: 2020-2028.
45. Sune, C., T. Hayashi, Y. Liu, W. S. Lane, R. A. Young, and M. A. Garcia-Blanco. 1997. CA150, a nuclear protein associated with the RNA polymerase II holoenzyme, is involved in Tat-activated human immunodeficiency virus type 1 transcription. Mol. Cell. Biol. 17: 6029-6039.
46. Deng, T., and M. Karin. 1993. JunB differs from c-Jun in its DNA-binding and dimerization domains, and represses c-Jun by formation of inactive heterodimers. Genes Dev. 7: 479-490.
47. Petrak, D., S. A. Memon, M. J. Birrer, J. D. Ashwell, and C. M. Zacharchuk. 1994. Dominant negative mutant of c-Jun inhibits NF-AT transcriptional activity and prevents IL-2 gene transcription. J. Immunol. 153: 2046-2051.
48. Hidalgo-Estevez, A. M., E. Gonzalez, C. Punzon, and M. Fresno. 2006. Human immunodeficiency virus type 1 Tat increases cooperation between AP-1 and NFAT transcription factors in T cells. J. Gen. Virol. 87: 1603-1612.
49. Minghetti, L. 2004. Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J. Neuropathol. Exp. Neurol. 63: 901-910.
50. Daniel, D. C., Y. Kinoshita, M. A. Khan, L. D. Valle, K. Khalili, J. Rappaport, and E. M. Johnson. 2004. Internalization of exogenous human immunodeficiency virus-1 protein, Tat, by KG-1 oligodendroglioma cells followed by stimulation of DNA replication initiated at the JC virus origin. DNA Cell Biol. 23: 858 - 867.
51. Bajetto, A., R. Bonavia, S. Barbero, P. Piccioli, A. Costa, T. Florio, and G. Schettini. 1999. Glial and neuronal cells express functional chemokine receptor CXCR4 and its natural ligand stromal cell-derived factor 1. J. Neurochem. 73: 2348-2357.
52. Vila-Coro, A. J., J. M. Rodriguez-Frade, A. Martin De Ana, M. C. Moreno-Ortiz, A. C. Martinez, and M. Mellado. 1999. The chemokine SDF-1α triggers CXCR4 receptor dimerization and activates the JAK/STAT pathway. FASEB J. 13: 1699-1710.
53. Minghetti, L., S. Visentin, M. Patrizio, L. Franchini, M. A. Ajmone-Cat, and G. Levi. 2004. Multiple actions of the human immunodeficiency virus type-1 Tat protein on microglial cell functions. Neurochem. Res. 29: 965-978.
54. Lipton, S. A. 1994. HIV displays its coat of arms. Nature 367: 113-114.
55. Dreyer, E. B., and S. A. Lipton. 1995. The coat protein gp120 of HIV-1 inhibits astrocyte uptake of excitatory amino acids via macrophage arachidonic acid. Eur. J. Neurosci. 7: 2502-2507.
56. Corasaniti, M. T., M. C. Strongoli, S. Piccirilli, R. Nistico, A. Costa, A. Bilotta, P. Turano, A. Finazzi-Agro, and G. Bagetta. 2000. Apoptosis induced by gp120 in the neocortex of rat involves enhanced expression of cyclooxygenase type 2 and is prevented by NMDA receptor antagonists and by the 21-aminosteroid U-74389G. Biochem. Biophys. Res. Commun. 274: 664-669.
57. Albini, A., S. Ferrini, R. Benelli, S. Sforzini, D. Giunciuglio, M. G. Aluigi, A. E. Proudfoot, S. Alouani, T. N. Wells, G. Mariani, et al. 1998. HIV-1 Tat protein mimicry of chemokines. Proc. Natl. Acad. Sci. USA 95: 13153-13158.
58. Zocchi, M. R., P. Contini, M. Alfano, and A. Poggi. 2005. Pertussis toxin (PTX) B subunit and the nontoxic PTX mutant PT9K/129G inhibit Tat-induced TGF-β production by NK cells and TGF-β-mediated NK cell apoptosis. J. Immunol. 174: 6054-6061.
59. Haughey, N. J., A. Nath, M. P. Mattson, J. T. Slevin, and J. D. Geiger. 2001. HIV-1 Tat through phosphorylation of NMDA receptors potentiates glutamate excitotoxicity. J. Neurochem. 78: 457-467.
60. Kaltschmidt, B., R. A. Linker, J. Deng, and C. Kaltschmidt. 2002. Cyclooxygenase-2 is a neuronal target gene of NF-κB. BMC Mol. Biol. 3: 16.
61. Alvarez, S., M. J. Serramia, M. Fresno, and M. A. Munoz-Fernandez. 2007. HIV-1 envelope glycoprotein 120 induces cyclooxygenase-2 expression in astrocytoma cells through a nuclear factor-κB-dependent mechanism. Neuromolecular Med. 9: 179-193.
62. Nath, A., K. Conant, P. Chen, C. Scott, and E. O. Major. 1999. Transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes: a hit and run phenomenon. J. Biol. Chem. 274: 17098-17102.
63. Chen, P., M. Mayne, C. Power, and A. Nath. 1997. The Tat protein of HIV-1 induces tumor necrosis factor-α production: implications for HIV-1-associated neurological diseases. J. Biol. Chem. 272: 22385-22388.
64. Lim, S. P., and A. Garzino-Demo. 2000. The human immunodeficiency virus type 1 Tat protein up-regulates the promoter activity of the β-chemokine monocyte chemoattractant protein 1 in the human astrocytoma cell line U-87 MG: role of SP-1, AP-1, and NF-κB consensus sites. J. Virol. 74: 1632-1640.
65. Pyrzynska, B., A. Lis, G. Mosieniak, and B. Kaminska. 2001. Cyclosporin Asensitive signaling pathway involving calcineurin regulates survival of reactive astrocytes. Neurochem. Int. 38: 409-415.
66. Jones, E. A., D. Sun, L. Kobierski, and A. J. Symes. 2003. NFAT4 is expressed in primary astrocytes and activated by glutamate. J. Neurosci. Res. 72: 191-197.
67. Milani, D., M. Mazzoni, P. Borgatti, G. Zauli, L. Cantley, and S. Capitani. 1996. Extracellular human immunodeficiency virus type-1 Tat protein activates phosphatidylinositol 3-kinase in PC12 neuronal cells. J. Biol. Chem. 271: 22961-22964.
68. Borgatti, P., G. Zauli, L. C. Cantley, and S. Capitani. 1998. Extracellular HIV-1 Tat protein induces a rapid and selective activation of protein kinase C (PKC)-α, and -ε and -ζ isoforms in PC12 cells. Biochem. Biophys. Res. Commun. 242: 332-337.
69. Brambilla, R., G. Burnstock, A. Bonazzi, S. Ceruti, F. Cattabeni, and M. P. Abbracchio. 1999. Cyclo-oxygenase-2 mediates P2Y receptor-induced reactive astrogliosis. Br. J. Pharmacol. 126: 563-567.
70. Bruce-Keller, A. J., A. Chauhan, F. O. Dimayuga, J. Gee, J. N. Keller, and A. Nath. 2003. Synaptic transport of human immunodeficiency virus-Tat protein causes neurotoxicity and gliosis in rat brain. J. Neurosci. 23: 8417- 8422.
71. Zhou, B. Y., Y. Liu, B. Kim, Y. Xiao, and J. J. He. 2004. Astrocyte activation and dysfunction and neuron death by HIV-1 Tat expression in astrocytes. Mol. Cell. Neurosci. 27: 296-305.
72. Fiebich, B. L., S. Schleicher, O. Spleiss, M. Czygan, and M. Hull. 2001. Mechanisms of prostaglandin E2-induced interleukin-6 release in astrocytes: possible involvement of EP4-like receptors, p38 mitogen-activated protein kinase and protein kinase C. J. Neurochem. 79: 950-958.
73. Hirst, W. D., K. A. Young, R. Newton, V. C. Allport, D. R. Marriott, and G. P. Wilkin. 1999. Expression of COX-2 by normal and reactive astrocytes in the adult rat central nervous system. Mol. Cell. Neurosci. 13: 57-68.
74. Flora, G., H. Pu, B. Hennig, and M. Toborek. 2006. Cyclooxygenase-2 is involved in HIV-1 Tat-induced inflammatory responses in the brain. Neuromolecular Med. 8: 337-352.